Natco Pharma net profit increased 11.85 per cent at ₹217 crore in the third quarter ended December 31, 2017, against ₹194 crore in the corresponding quarter of the previous year. Total revenue, however, declined from ₹685 crore to ₹573 crore.

The board of directors has declared second interim dividend of ₹7 on each equity share of ₹2 each for the year 2017-18 which is 350 per cent on the nominal value of the share.